Vasudev Bailey, PhD, is a Senior Partner at ARTIS Ventures where he focuses on investing in novel and breakthrough health and life sciences companies. He currently sits on several boards, including Eko, Excision BioTherapeutics, Outpace, Seed Health, Johns Hopkins Biomedical Engineering, Delix Therapeutics and The Trevor Project. He has led investments for the firm in Freenome, Cerebral, and Lemonaid Health. Vasudev received his PhD in Biomedical Engineering, Johns Hopkins School of Medicine where he was a Siebel and a Medtronic Scholar and graduated phi beta kappa and magna cum laude from UCI.
Keynote
Venture Capital
Medtech, Biotech
Corporates
Company backgrounds and useful links.
Artis Ventures
Vasudev Bailey
ARTIS Ventures : TechBio
Artis Ventures is based in San Francisco and is well known for some historic wins including being an early investor in Facebook, leading the Series B in Youtube and being the first institutional capital into Stemcentrx. Their focus is TechBio: the integration of multiple, historically distinct scientific and technological disciplines into a single dynamic ecosystem—promises to transform existing models of health care with a combination of digital innovation and advances in life science research. c
